Patient ID,Age,Gender,Country,State,City,Facility,Race,Ethnicity,HCW,Smoking_Status,Blood_type,Allergies,"Significant comorbidities (e.g., cancer, cardiovascular disease, diabetes)",Recent_Surgery,Other_Procedures,Concomitant_medications,Facility_Name,Facility_Country,Facility_State,City,Treatment_ setting,First_symptom_date,First_consultation_date,COVID-19_Diagnosis_date,"Symptoms at disease onset (e.g.,  mild fever, cough (dry), sore throat, nasal congestion, malaise, headache, muscle pain, or malaise)",COVID-19_lab_test date,COVID-19_diagnosis_test,Laboratory_positive,COVID-19 diagnosis,Mode of exposure,Admission from community (home) ,"Admission from institution (prison, nursing home, etc)","Current symptoms (e.g.,  mild fever, cough (dry), sore throat, nasal congestion, malaise, headache, muscle pain, or malaise)",Blood pressure,heart rate,Respiratory rate,Temperature,Symptom duration (before diagnosis/hospitalization/diagnosis),Severity of COVID-19,COVID-19 specific treatment,COVID-19 specific treatment effect,COVID-19 medications ,COVID-19 dosing regimen,Hospitalization,Date of admission,Days hospitalized,Admitted to ICU (Y/N),ICU_Date_of_admission,ICU course of disease,Coinfection,Coinfection (detail),Superinfection (Y/N),Superinfection (details),COVID-19 complications,Recovered from COVID-19 (Y/N),Potential candidate for donation of convalescent plasma (Y/N),Enrolled in clinical trial (Y/N),O2 (Y/N),On ventilation (Y/N),Days on mechanical ventilation,extracorporeal membrane oxygenation ECMO,"Other cytokines (e.g., IFN-gamma, TNF-alpha, IL-1, GM-CSF)",Pressors ,Continuous Renal Replacement Therapies CRRT ,"Imaging (e.g., CT) results",WBC,ALC,ANC,AEC,Hgb,PLT,Other labs,Creatine,T Bili,AST,ALT,PT,APTT,D dimer,LDH,TNI,BNP,CRP,Il6,GFR/Creatinine Clearance,Ferriti,"SARS-CoV-2 viral load/titer (PCR, serology)",SARS-CoV-2 RNA Detection-Qualitative (e.g. detected or not detected),"SARS-CoV-2 RNA Level-Quantitative (e.g., Ct value, or copies/mL)","SARS-CoV-2 Virus Level (e.g. PFU/mL, TCID50)","Virus amino acid substitution data, including viral target protein, specific amino acid position and substitution, and frequency in population (this is very high level and no doubt we would have a request for more detailed resistance data)","SARS-CoV-2 IgM, IgG or Neutralizing Antibody (e.g., ELISA titer or PRNT50 titer)","Serum cytokine (e.g., IFN-gamma, TNF-alpha, IL-1, GM-CSF)",Other Labs
,34,M,USA,NY,New York,hospital,asian,hispanic,Y,current,A,penicillian,,jfjd,,insulin,,,,,inpatient,3/1/20,3/5/20,3/25/20,dry mouth,3/1/20,blood,Y,cd0s8-3,fdasfa,Y,Y,,,,,,,mild ,drugs,curative,Y,Y,Y,3/24/20,20,Y,3/26/20,,Y,text,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,49,F,China,CA,wuhan,nursing home,white,not hispanic,N,former,A-B,pollen,,fjdidj,,ibuprofen,,,,,outpatient,3/3/20,3/9/20,3/31/20,headache,3/1/20,saliva,N,fjsys-19,dfjads,N,N,,,,,,,moderate,drugs,fjddiodi,N,N,N,3/24/20,6,N,3/26/20,,N,text,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,